Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services primarily to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is headquartered in Toronto, Canada.
Stock data | 2023 | Change |
---|---|---|
Price | $0.03655104353229285 | N/A |
Market Cap | $5.93M | N/A |
Shares Outstanding | 162.14M | 48.07% |
Employees | 0 | N/A |
Shareholder Equity | 11.06M | 101.75% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 1.22 | N/A |
P/S Ratio | 1.27 | N/A |
P/B Ratio | 0.54 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.3858 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $4.68M | N/A |
Earnings | $4.27M | N/A |
EPS | 0.03 | N/A |
Earnings Yield | 0.8208 | N/A |
Gross Margin | 0.7243 | N/A |
Operating Margin | 0.1552 | N/A |
Net income margin | 0.9117 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $17.21M | N/A |
Total Debt | $6.15M | N/A |
Cash on Hand | $1.90M | N/A |
Debt to Equity | 0.8252 | -60.35% |
Cash to Debt | 0.3090 | -1.59% |
Current Ratio | 0.9176 | 119.13% |